Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

China Halts IPOs in Move to Stop Stock Market Decline

publication date: Jul 6, 2015
China ordered a halt to new IPOs on its two domestic exchanges, Shanghai and Shenzhen. The move seeks to stop a precipitous month-long decline of over 30% in the exchange indexes, including a 7% drop last Friday. The government hopes the hiatus in new offerings will encourage investors to hold on to their present holdings, rather than selling them to buy new offerings. In addition, the nation's largest stock brokerage companies agreed to buy $19.3 billion worth of stock in already public companies, another move that could support stock prices. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital